Full Text
HTA32 Analysis of Pros Included in the HTA Assessment of Conditionally Approved Oncology Drugs in the UK, Italy, and Germany

Abstract

Authors

Mark Chalmers Vidhyasagari Sundaram PRATEEK KANADE Mansi Deshpande Rory Dunne

Back to Volume 28, Supplemental Issue 12S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×